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Background: Population-based household surveys, notably the Demographic and Health Surveys (DHS) and
Multiple Indicator Cluster Surveys (MICS), remain the main source of maternal and newborn health data for many
low- and middle-income countries. As part of the Every Newborn Birth Indicators Research Tracking in Hospitals (EN-
BIRTH) study, this paper focuses on testing validity of measurement of maternal and newborn indicators around the
time of birth (intrapartum and postnatal) in survey-report.
Methods: EN-BIRTH was an observational study testing the validity of measurement for selected maternal and
newborn indicators in five secondary/tertiary hospitals in Bangladesh, Nepal and Tanzania, conducted from July
2017 to July 2018. We compared women’s report at exit survey with the gold standard of direct observation or
verification from clinical records for women with vaginal births. Population-level validity was assessed by validity
ratios (survey-reported coverage: observer-assessed coverage). Individual-level accuracy was assessed by sensitivity,
specificity and percent agreement. We tested indicators already in DHS/MICS as well as indicators with potential to
be included in population-based surveys, notably the first validation for small and sick newborn care indicators.
Results: 33 maternal and newborn indicators were evaluated. Amongst nine indicators already present in DHS/
MICS, validity ratios for baby dried or wiped, birthweight measured, low birthweight, and sex of baby (female) were
between 0.90–1.10. Instrumental birth, skin-to-skin contact, and early initiation of breastfeeding were highly
overestimated by survey-report (2.04–4.83) while umbilical cord care indicators were massively underestimated
(0.14–0.22). Amongst 24 indicators not currently in DHS/MICS, two newborn contact indicators (kangaroo mother
care 1.00, admission to neonatal unit 1.01) had high survey-reported coverage amongst admitted newborns and
high sensitivity. The remaining indicators did not perform well and some had very high “don’t know” responses.
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Conclusions: Our study revealed low validity for collecting many maternal and newborn indicators through an exit
survey instrument, even with short recall periods among women with vaginal births. Household surveys are already
at risk of overload, and some specific clinical care indicators do not perform well and may be under-powered.
Given that approximately 80% of births worldwide occur in facilities, routine registers should also be explored to
track coverage of key maternal and newborn health interventions, particularly for clinical care.
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What is known and what is new about this study?
• Population-based household surveys are the primary source of ma-
ternal and newborn health data for many low- and middle-income
countries (LMICs). While surveys are important data sources, especially
where coverage of robust routine health data systems remains low, they
are also infrequent, expensive and have been shown to have limited val-
idity for some aspects of perinatal care.
• EN-BIRTH is the largest validation study to date of maternal and
newborn health indicators, across five hospitals in three countries, in-
cluding > 14,000 exit surveys. This dataset enabled validity analyses to
be made for 33 maternal and newborn indicators comparing gold-
standard observation or case notes verification to exit survey-reported
coverage and outcomes.
• This is the first validity testing for hospital-based clinical care of
small and sick newborns (e.g. resuscitation, kangaroo mother care, and
neonatal infection management).
What does this say about nine indicators already in MICS and/or
DHS core or additional modules?
• 4 out of 9 indicators were accurately estimated by survey report at
the pooled population level: baby dried or wiped immediately after
birth (observed coverage: 90.5%, survey: 96.8%), birthweight measured
(observed: 98.6%, survey: 93.8%), sex (observed female: 48.8%, survey-
reported female: 49.1%) and low birthweight (based on observed
weight: 15.2%, based on survey-reported weight: 14.1%).
• Early initiation of breastfeeding (observed: 14.4%, survey: 69.5%),
and skin-to-skin contact (observed: 41.2%, survey: 84.2%) were highly
overestimated in the exit survey.
• Application of a substance to the umbilical cord was massively
(> 76%) underestimated in survey-report compared with observed
coverage for anything applied to the cord or chlorhexidine applied
to the cord, largely driven by “don’t know” responses (24.1–75.2%).
• Besides application of a substance/chlorhexidine to the umbilical
cord, “don’t know” responses were < 10% for other indicators already in
DHS/MICS.
Which questions are not appropriate for surveys?
• Validity of indicators not already in DHS/MICS was affected by high
“don’t know” responses (> 20%), varying widely by hospital e.g. birth
attendant listened to fetal heart sounds during labour, oxytocin given,
antenatal corticosteroids given before birth, baby received injectable
antibiotics, any diagnostic/blood test done.
• Clinical care indicators had low validity: any infection (percent
agreement 47.1%) or sepsis (percent agreement 26.6%). Newborn
resuscitation had high percent agreement and high specificity but low
sensitivity. Moreover, indicators for the small and sick newborn target
group may be underpowered even in large national household surveys.
What next and research gaps?
• Consistent with other studies, we found lower validity for clinical
interventions and time-bound questions. Further research is needed on
time-bound indicators to explore how the accuracy of crucial indicators
such as early initiation of breastfeeding can be improved, e.g. if the time
component were to be dropped.
• Women whose newborns were admitted to a neonatal or KMC
ward reported this accurately; however, to be useful in population-
based surveys, we would need to know how people not admitted
would respond.
• Improved, respectful communication with families regardingKey findings (Continued)
clinical interventions for small and sick newborns is needed for both
quality care and accuracy of survey-reported coverage. Families cannot
report on clinical care if they were never informed.Background
Globally each year, 2.4 million newborns die in the first
month of life, more than 2 million babies are stillborn
and around 295,000 women die of maternal causes, the
vast majority in low- and middle-income countries
(LMICs) [1–4]. Most of these deaths can be prevented
by high coverage and quality care during pregnancy and
childbirth, and for small and sick newborns [5]. The Sus-
tainable Development Goals include a target to reduce
the national neonatal mortality rate to fewer than 12 per
1000 live births, and the global average maternal mortal-
ity ratio to fewer than 70 per 100,000 live births by 2030
[6]. To track the progress, and the linked stillbirth target
of fewer than 12 stillbirths per 1000 total births, the
Every Newborn Action Plan (ENAP) was launched in
2014. In close alignment with the World Health
Organization Strategy for Ending Preventable Maternal
Mortality, some indicators were prioritised for maternal
and newborn care [7, 8]. Unfortunately, in the countries
where most of the maternal and newborn deaths occur,
data gaps for coverage and quality of care impede health
systems improvement needed to drive progress towards
universal health coverage [9].
Currently, most LMICs are reliant on retrospective
data based on women’s self-report collected through
household surveys, such as the Demographic and Health
Surveys (DHS) and Multiple Indicator Cluster Surveys
(MICS) [10, 11]. However, these population-level surveys
track a limited number of indicators that measure ma-
ternal and newborn care and have focused especially on
“contact points” such as antenatal care, skilled birth at-
tendance, facility birth, and postnatal care. The DHS
core women’s questionnaire has over 400 questions and
takes 30–60 min to complete for most women; there is
understandable reluctance to add more questions on
maternal and newborn health.
Given the shift to evidence-based measurement, there
is more demand for validation studies on indicators
already in surveys, and to inform selection of new
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paring survey measures of an indicator to a gold stand-
ard data source [12]. Several studies have assessed
validity of women’s self-report in high income or upper
middle-income countries using clinical records as the
gold standard [13–26]. Other studies have sought to val-
idate women’s reports of events related to care around
the time of birth in LMICs using direct observation as
the gold standard; however, these studies often had a
small sample size and/or were conducted in one or two
facilities [27–30]. These studies have found variable val-
idity for some indicators including uterotonic adminis-
tration, early initiation of breastfeeding and skin-to-skin
contact, indicating need for further research in add-
itional contexts. Previous validity studies have not been
conducted in Bangladesh or Tanzania and those in
Nepal have been limited to birthweight and gestational
age [31]. Furthermore, no published studies have re-
ported on validity of women’s reports for new indicators
related to the care of small and sick newborns such as
kangaroo mother care (KMC) for low birthweight babies
or injectable antibiotics for newborn sepsis.
The Every Newborn Action Plan, agreed by all
United Nations member states and > 80 development
partners, includes an ambitious measurement
improvement roadmap to validate measurement of
indicators for care and outcomes around the time of
birth [7, 32]. As part of this roadmap, the Every
Newborn – Birth Indicators Research Tracking in
Hospitals (EN-BIRTH) study was an observational
study of > 23,000 women to test the validity of
measurement for selected indicators [33].Fig. 1 Survey validation design, EN-BIRTH study. Exact wording for survey qObjectives
This paper is part of a supplement based on the EN-
BIRTH multi-country validation study, ‘Informing
measurement of coverage and quality of maternal and
newborn care’ and focuses on women’s report surveys,
with the following objectives:
1. Assess the VALIDITY of measurement for nine
current DHS/MICS indicators that measure care
during the intrapartum and immediate postpartum
period for women with vaginal births.
2. Explore 24 POTENTIAL MATERNAL AND
NEWBORN INDICATORS, including indicators
for care of small and sick newborns that could be
included in population surveys (e.g. DHS/MICS)
and assess their validity and measurement quality.
Methods
Study settings and design
EN-BIRTH was a mixed-methods, observational study
comparing observer-assessed coverage (considered the
gold standard) of selected maternal and newborn inter-
ventions to coverage measured by women’s report at exit
survey and routine register records; this paper focuses
on survey-report (Fig. 1). Data were collected from July
2017 to July 2018 in five public secondary/tertiary com-
prehensive emergency obstetric and newborn care
(CEmONC) hospitals in three high burden countries:
Maternal and Child Health Training Institute, Azimpur
and Kushtia General Hospital in Bangladesh (BD);
Pokhara Academy of Sciences in Nepal (NP); Temeke
District Hospital and Muhimbili National Referraluestions detailed in Additional file 1
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ing the research protocol [33] and overall validity results,
including for routine register data, has been published
separately [34].
Participants were pregnant women being admitted to
labour/delivery wards (exclusion criteria at admission
were imminent birth and no fetal heart beat heard,
participants were not automatically excluded based on
age), mother-baby pairs admitted in KMC corners/wards
(all admissions were eligible) and newborns admitted to
inpatient wards for treatment of presumed severe neo-
natal infection (neonates with clinically defined infec-
tion—sepsis, pneumonia, meningitis—were eligible).
Trained clinical researchers observed participants 24 h
per day and recorded data on care and outcomes in
three clinical settings: labour and delivery ward, operat-
ing theatre, and KMC corners/wards. Verification of in-
patient records were used as the gold standard for
newborns who received antibiotics for presumed severe
infection, and for women who received antenatal corti-
costeroids (ACS) for risk of preterm birth. Women were
surveyed at the time of discharge before leaving the facil-
ity by a separate cadre of data collectors. Training for
survey data collectors was based on DHS training mate-
rials. In the case of multiple births, women were asked
only about the first birth. All data were collected using a
custom-built android tablet-based application. All data
collectors and study staff received standardised training
on the study procedures and data collections tools.
We compared observer-assessed coverage of care
and outcomes for women with vaginal births to
women’s reports at exit survey. Women who give
birth vaginally on labour wards have a very different
experience than those giving birth by caesarean in op-
erating theatre; thus we have analysed these separ-
ately. Differences between vaginal birth and caesarean
birth for indicator accuracy are reported elsewhere for
five indicators [34] and for specific indicators
throughout this supplement series [35–38]. Further
work is ongoing to examine quality of care and meas-
urement accuracy for women with caesarean sections.
Indicator selection
At the study design phase, we conducted a mapping
review of the MICS women’s questionnaire as well as
DHS-7 core women’s questionnaire and newborn care
additional module to identify maternal and newborn in-
dicators from the intrapartum and immediate postnatal
period for which we could test validity in a hospital set-
ting. To identify maternal and newborn indicators that
have the potential to be included in population-based
surveys, we referred to the Ending Preventable Maternal
Mortality, Every Newborn Action Plan strategy documents
and earlier studies testing validity of measurement formaternal and newborn indicators [7, 8]. As a result of up-
dates to DHS questionnaires (DHS-8) and the new supple-
mental module on maternal health care, we conducted an
additional mapping review prior to data analysis. We se-
lected 33 maternal and newborn indicators for analysis
(nine indicators already existing in DHS/MICS and 24 in-
dicators having the potential to be included in population-
based surveys). The indicator list is shown in Fig. 2 and
the exact wording for questions in EN-BIRTH, DHS and
MICS is shown in Additional file 1.
Analysis
To calculate observer-assessed coverage and survey-
reported coverage, we used a relevant denominator from
the EN-BIRTH dataset (total deliveries/ total births/ live-
births/ admitted to KMC ward/ admitted to inpatient
for suspected neonatal infection, etc.) (Additional file 2)
and expressed results as a percentage. “Don’t know”
survey responses were also reported separately as a per-
centage. We calculated validity ratios, similar to verifica-
tion ratios in data quality review (DQR) methods,
calculating survey-coverage divided by observed cover-
age where “don’t know” responses were treated as “no”
(Additional file 3). A ratio > 1 shows overestimation of
survey-reported coverage compared to observed, while a
ratio < 1 shows an underestimate. We used standard
DQR cut-offs (over/underestimate by 0–5% = Excellent,
by 6–10% = Very good, by 11–15% =Good by, 16–20% =
Moderate and by > 20% = Poor) for heat maps [39].
For individual-level validity reporting, we constructed
two-way tables comparing observer-assessed coverage to
survey-reported coverage. In line with DHS and com-
mon survey reporting, we combined survey “don’t know”
responses with “no”, except for the low birthweight indi-
cator where “don’t know” was excluded from the numer-
ator and denominator [40]. Additional analysis for
selected indicators is presented in Additional file 4 with
“don’t know” excluded from the analysis (numerator and
denominator).
As interventions/conditions with very high or very
low coverage/prevalence may result in a small sample
size for individual-level validity “diagnostic test”
methods (low cell counts in two way tables), we report
percent agreement for all indicators. Where column to-
tals are ≥10 in the two way tables and “don’t know” re-
sponses were < 20%, we calculated sensitivity (true
positive rate) and specificity (true negative rate) of
survey-reported coverage to measure observed coverage
(gold standard). Positive predictive value (PPV), nega-
tive predictive value (NPV), area under the curve
(AUC), and inflation factor (IF) were also calculated.
Percentage observed to have an intervention or out-
come among women replying “don’t know” for indica-
tors included in DHS/MICS were calculated. 95%
Fig. 2 List of indicators tested for validity, EN-BIRTH study
Ameen et al. BMC Pregnancy and Childbirth 2021, 21(Suppl 1):238 Page 5 of 17confidence intervals were calculated assuming a binom-
inal distribution. Validity analysis pooled results were
calculated using random effects meta-analysis, pre-
sented with i2, τ2, and heterogeneity statistic (Q). Miss-
ing values from the observation dataset were excluded
from the relevant analysis [12].
To determine reliability of the observational data
(gold standard), study supervisors simultaneously
observed births with data collectors for a 5% subset of
cases. We calculated percent agreement and Cohen’s
kappa coefficients of agreement for core indicators.
Percent agreement between the two observers ranged
between 85.0–100% by indicator and site. Kappa scores
had a wider range (0–1), however, some low kappa
scores were affected by prevalence and an imbalance in
marginal totals. We included all indicators in the
analysis and discussion on low kappa coefficients has
been done elsewhere [34].All statistical analyses were conducted using Stata
(version 16) [41] and results are reported in accordance
with STROBE statements checklists for cross-sectional
studies (Additional file 5) [42].
Results
Study participants
Three types of participants were involved in this study
(Fig. 3). Amongst 23,015 women observed in labour
and delivery wards, 16,030 had vaginal births resulting
in 16,298 newborns (including twins and stillbirths).
Exit surveys were conducted with 14,543 of these
women (90.7%). Out of 842 mother-baby pairs
admitted in KMC wards/corners, 840 pairs were
observed (99.8%). Exit surveys were conducted with 652
women (77.6%). A total of 1523 babies were identified
in the inpatient wards, 1015 met eligibility criteria for
presumed severe infection (diagnosis of sepsis,
C) Neonatal infectionB) Kangaroo mother care
   Case note verification (gold standard)






Consent not given n=48
Consented
n=1,015
A) Labour and delivery ward
   Register-recorded data not presented
   Clinical observation (gold standard)
Survey-reported data   
Women consented
n=23,724
Women (vaginal births) n=16,030
Babies (vaginal births) n=16,298









Missing mode of birth n=287
Not approached n=1,187
Consent not given n=300
   Register-recorded data not presented
   Clinical observation (gold standard)























Fig. 3 Flow Diagram: a Labour and Delivery b Kangaroo Mother Care c Neonatal Infection, EN-BIRTH study
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100% and exit surveys were conducted with 910 women
(89.7%). Reasons for non-participation in the exit sur-
vey included refusal and discharge prior to being
approached for the survey.
The background characteristics of the participants are
presented in Table 1, with details by site in Additional
files 6, 7 and 8. One-third (37.3%) were age 20–24, more
than 40% completed secondary education and half
(51.1%) were pregnant for the first time. Among the
babies who were observed in the KMC ward, 97.0% were
less than or equal to 2000 g. Among the babies who
were admitted in the inpatient ward for presumed severe
infection and met the eligibility criteria, two-thirds were
less than 7 days old at the time of admission.
Indicators already captured in MICS/DHS
Four out of nine indicators were accurately estimated by
survey report at the pooled population level. Indicators
with a time component (early breastfeeding and skin-to-
skin contact) were over-reported while umbilical cord
care indicators were under-reported. Instrumental birth
had very low coverage and was overreported in survey.
Figure 4 and Additional file 9 present the observer-
assessed coverage and survey-reported coverage along
with the percentage of “don’t know” responses. Sensitiv-
ity, specificity, and percent agreement are presented in
Fig. 5 and Additional files 10 and 11.
Mode of birth (instrumental birth) had very low “don’t
know” responses across all hospitals (< 1%, Fig. 4,
Additional file 9). Observed coverage of instrumental
birth was low (0.5%) while survey reported coverage was
1.9%. While percent agreement was 98.2% the validity
ratio was “poor” (3.80) (Fig. 5). Individual level validity
statistics could only be calculated for Pokhara NP due to
low cell counts in two-way tables and showed lowsensitivity (61.7%) and high specificity (99.5%,
Additional file 10).
Immediate newborn care indicators ranged in coverage
and performance. Immediate drying and birthweight
measured had high observed coverage (> 90%) and low
levels of “don’t know” responses (< 5%). While sensitivity
was high (> 94%), specificity was low (4.1% for immediate
drying, 48.8% for birthweight measured) and validity
ratios were classified as “very good” (immediate drying:
1.07) and “excellent” (birthweight measured: 0.95). Early
initiation of breastfeeding and skin-to-skin contact were
both largely overestimated by the survey despite low levels
of “don’t know” responses (< 1%). Observed coverage of
early initiation of breastfeeding was very low (< 14.4%),
while survey-reported coverage was 69.5%. While sensitiv-
ity was high (82.5%), specificity was low (35.9%) and valid-
ity ratio was “poor” (4.83). Observed coverage of skin-to-
skin contact was 41.2%, while survey-reported coverage
was 84.2%. Sensitivity was high (84.7%) while specificity
was low (18.1%) and validity ratio was “poor” (2.04). Cord
cleansing with chlorhexidine was nearly universal (97.9%)
in the three hospitals with a chlorhexidine policy
(Bangladesh and Nepal). Survey-reported coverage, how-
ever, had a large range. While survey-reported coverage of
any cord cleansing and chlorhexidine application was very
low in Azimpur BD (1.9% and 0.5%, respectively) survey-
reported coverage for these interventions was higher in
Kushtia BD (70.1% and 46.1%, respectively). Overall, sensi-
tivity was low (21.7% for anything applied to the cord;
13.9% chlorhexidine) and specificity was higher (79.1%
anything applied; 92.6% chlorhexidine). Validity ratios
were “poor” (0.22 and 0.14).
Newborn outcomes such as sex of the baby and low
birthweight were well estimated by the survey. Sex of
the baby had very low “don’t know” responses (< 1%)
with high sensitivity, high specificity (> 97%) and
Table 1 Characteristics of women and babies, EN-BIRTH study






Total women 16,030 840 1015
Woman’s age
< 18 years 318 (2.0) 30 (3.6) 26 (2.6)
18–19 years 1803 (11.2) 103 (12.3) 128 (12.6)
20–24 years 5978 (37.3) 292 (34.8) 352 (34.7)
25–29 years 4371 (27.3) 211 (25.1) 285 (28.1)
30–34 years 2338 (14.6) 132 (15.7) 151 (14.9)
35+ years 1222 (7.6) 72 (8.6) 73 (7.2)
Woman’s education
No education 503 (3.1) 34 (4) 34 (3.3)
Primary incomplete 414 (2.6) 16 (1.9) 36 (3.5)
Primary complete 584 (3.6) 38 (4.5) 79 (7.8)
Secondary incomplete 6437 (40.2) 399 (47.5) 400 (39.4)
Secondary complete or higher 7644 (47.7) 340 (40.5) 436 (43.0)
Don’t know 448 (2.8) 13 (1.5) 30 (3.0)
Birth order
Nullipara 8199 (51.1) 0 (0.0) 0 (0.0)
Primipara 4606 (28.7) 421 (50.1) 627 (61.8)
Multipara (2–4) 3062 (19.1) 341 (40.6) 344 (33.9)
Grand Multipara (5+) 126 (0.8) 77 (9.2) 38 (3.7)
Don’t know 34 (0.2) 1 (0.1) 6 (0.6)
Missing 3 (0.0) 0 (0.0) 0 (0.0)
Mode of birth
Normal vertex birth 15,661 (97.7) – –
Vaginal breech 93 (0.6) – –
Vacuum/Forceps 276 (1.7) – –
Baby Total 16,298 840 1015
Sex
Male/Boy 11,902 (50.7) 379 (45.1) 624 (61.5)
Female/Girl 11,042 (47) 458 (54.5) 391 (38.5)
Ambiguous 31 (0.1) 1 (0.1) 0 (0.0)
Missing 496 (2.1) 2 (0.2) 0 (0.0)
All sites, unweighted
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birthweight of the baby, which was then categorized into
low (< 2500 g) or normal birthweight (≥2500 g). “Don’t
know” responses to birthweight were moderate (4.8%).
For low birthweight classification, sensitivity was 83.4%,
specificity was 97.1% and validity ratio was “very good”
(0.93).
“Don’t know” responses analysis considerations
Among women who replied “don’t know” in the survey,
the proportion observed to have the intervention or
outcome is presented in Table 2. Of those who didn’tknow if their baby was dried or wiped immediately after
birth, most (79.2%) were observed to be dried/wiped.
Similarly, for women who didn’t know about birthweight
measurement or cord care practices, most were observed
as completed (birthweight measured: 91%, anything
applied to cord: 97.4%, Chlorhexidine applied to cord:
97.2%). However, for interventions involving women
themselves, such as placing the newborn skin-to-skin or
initiation of breastfeeding, observed coverage among
women responding “don’t know” in survey was low.
Validity results with “don’t know” responses excluded
are shown in Additional file 4. When “don’t know”
Fig. 4 Coverage for selected indicators, EN-BIRTH study. 1These indicators are not interventions and prevalence is reported for these indicators.
2Not asked in Tanzania. 3"Don’t Know" is excluded from numerator and denominator. Validity ratio calculated as survey-coverage/observed
coverage. Observed data: labour and delivery ward n = 16,030 women, 16,298 newborns; kangaroo mother care n = 840; neonatal infection
n = 1015. Survey data: labour and delivery ward n = 14,543 women; kangaroo mother care n = 652; neonatal infection n = 910
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Fig. 4 Coverage for selected indicators, EN-BIRTH study. 1These indicators are not interventions and prevalence is reported for these indicators.
2Not asked in Tanzania. 3"Don’t Know" is excluded from numerator and denominator. Validity ratio calculated as survey-coverage/observed
coverage. Observed data: labour and delivery ward n = 16,030 women, 16,298 newborns; kangaroo mother care n = 840; neonatal infection
n = 1015. Survey data: labour and delivery ward n = 14,543 women; kangaroo mother care n = 652; neonatal infection n = 910
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Fig. 5 (See legend on next page.)
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Fig. 5 Individual-level validation in exit survey for selected indicators, EN-BIRTH study. 1Validation not done because “Don’t Know” response
> 20%. 2Validation not done because ten or fewer observations per column of the two-way table. 3Not asked in Tanzania. Observed data: labour
and delivery ward n = 16,030 women, 16,298 newborns; kangaroo mother care n = 840; neonatal infection n = 1015. Survey data: labour and
delivery ward n = 14,543 women; kangaroo mother care n = 652; neonatal infection n = 910
Table 2 Percentage observed to have intervention/outcome despite reporting “don’t know” for indicators included in DHS/MICS,
EN-BIRTH study

















Mode of birth- Instrumental birth % Observed as
instrumental birth




0 2 3 4 1 10
Immediate newborn care:
Baby dried or wiped immediately
after birth




70 9 98 21 22 220
Baby placed naked against
mother’s skin




8 0 346 16 5 375
Early initiation of breastfeeding
(within 1 h after birth)
% Observed breastfeeding
within 1 h




1 4 15 43 27 90




62 50 123 490 30 755
Anything applied to cord % Observed anything
applied to cord




555 315 4485 −1 −1 5353
Chlorhexidine applied to cord % Observed chlorhexidine
applied to cord




565 629 4508 −1 −1 5700
Newborn outcomes:




0 1 7 5 3 16
Weight of the baby - < 2500 g % classified low
birthweight (< 2500 g)




110 96 308 1097 102 1713
1 = Not asked in Tanzania
For indicators included in DHS/MICS
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cord and chlorhexidine applied to the cord, individual-
level validity improved. Other indicators had low “don’t
know” responses and little change to validity when these
were excluded.
Indicators not currently in DHS/MICS
Contact point coverage indicators with potential for surveys
Survey measurement was tested for two contact
indicators for small and sick newborns, validity ratios
were “excellent” among admitted newborns. Among
women whose newborns were admitted to a neonatal
unit for treatment of infection, 98.8% reported their
newborns were admitted to a neonatal unit, and “don’t
know” responses were < 1%. Women whose newborns
were not admitted and did not have an infection
diagnosis were not asked about admission to a neonatal
unit. Similarly, both observed and survey reported
coverage of KMC among women whose newborns were
admitted to KMC corners/wards was universal. Percent
agreement was 100%, however this must be interpreted
with caution due to 100% coverage.
Content indicators with limited potential for surveys
Of the remaining 22 content indicators, seven had
validity ratios of “good” or better when pooled across
sites, however none were consistently good across all
sites. Questions related to clinical interventions during
labour and childbirth, such as listening to fetal heart
sounds or administration of uterotonics, did not perform
consistently well in the survey. While listening to fetal
heart sounds had high sensitivity (> 98%), specificity was
very low, < 6%. Questions around uterotonics had
variable percent agreement, sensitivity and specificity.
Observed coverage of any resuscitation (stimulation,
suction, bag-mask-ventilation (BMV)) was 17.1% where
coverage was highest for stimulation (16.6%) and BMV
coverage was 5%. Survey-reported stimulation was 1.3%,
underestimating observed stimulation by 15.3 percentage
points (validity ratio: 0.08). While specificity was high
(> 99%) sensitivity was less than 7%. Similarly, suction
and BMV were overestimated by surveys and had high
specificity (> 99%), low sensitivity (< 12%), and “poor”
validity ratios (< 0.22).
Among women whose newborns were admitted to a
neonatal unit for infection, very few were able to report
that their baby had an infection, and survey-reported
prevalence underestimated verified prevalence by 24.6–
82.9 percentage points with a “poor” validity ratio (0.47).
Survey-reported receipt of injectable antibiotics was
under-estimated in surveys by 6.4–45.0 percentage points,
and “don’t know” responses ranged from 9.7–35.2% (valid-
ity ratio: 0.77). Patient notes verified oxygen administra-
tion ranged from 17.2–47.2% and survey-report rangedfrom underestimating oxygen administration by 6.4 per-
centage points to overestimating it by 23.9 percentage
points (validity ratio: 0.79). “Don’t know” responses for
diagnostic testing ranged from 1.6–40.4%. While in
Pokhara NP there were few “don’t know” responses (1.6%)
and survey-reports were very close to notes of verified
coverage (within 1%), in Muhimbili TZ “don’t know” re-
sponses were 25.6% and verified coverage was underesti-
mated by 18.6 percentage points.
Amongst women whose newborn was admitted to KMC
corners/wards, while nasogastric feeding was low (0–17.0%)
with a “poor” validity ratio (1.32), intravenous feeding
support ranged from 55.2–72.8% and was underestimated
by survey-report by 28.7–66.8 percentage points. Coverage
of phototherapy ranged from 6.6–43.8% and was close to
survey-reported coverage (validity ratio: 0.84).
Prevalence of postpartum haemorrhage ranged from
1.7–3.9% and had high specificity (> 95%) but low
sensitivity (< 27%).
Discussion
Currently, population-based surveys capture limited data
on maternal and newborn care and few validity studies
have evaluated available or potential indicators. EN-
BIRTH study across five hospitals in three countries in-
cluded > 14,000 women with vaginal births observed and
with exit surveys, seven times more births than any pre-
vious maternal and newborn indicator validation study.
Our dataset enabled validity analyses for measurement
of 33 maternal and newborn indicators comparing time-
stamped gold-standard observation to exit survey-
reported indicators of coverage and outcomes, with nine
indicators currently included in DHS/MICS and new in-
dicators with potential for inclusion.
Overall, we found 4 of 9 indicators already in DHS/
MICS performed well in surveys. Of indicators not
already in DHS/MICS, “contact” indicators for small and
sick newborns (admission to a neonatal unit or KMC
ward) may be useful in population-based surveys while
indicators on content of clinical care had high levels of
“don’t know” responses and limited validity. Where pre-
vious validation research has shown mixed results, for
example uterotonics for prevention of postpartum haem-
orrhage [26–30], we found survey report under-
estimated true coverage by 10% whereas survey report
overestimated early initiation of breastfeeding by nearly
5 times.
This is the first validity testing for hospital-based clin-
ical care of small and sick newborns (e.g. resuscitation,
KMC, and neonatal infection management). EN-BIRTH
study allowed us to assess validity for these smaller
number of vulnerable newborns who needed special care
such as: neonatal resuscitation (5–10%) [43, 44], KMC
for newborns weighing ≤2000 g (10–20%) [45, 46] and
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[47], which have not been validated before, partly be-
cause of sample size challenges, but also because policy
attention is more recent [48]. Coverage of KMC was ac-
curate by survey-report in our study although exit survey
questions on KMC were asked only for those women
whose newborns were admitted to a KMC ward. Further
research is required to validate this indicator for all
women, including those not admitted to a KMC ward.
Population-based surveys, however, even when con-
ducted with large sample sizes, may be under-powered
to measure KMC targeted to stable newborns ≤2000 g.
Sample size calculations suggest that for current levels
of coverage of KMC for neonates ≤2000 g (believed to be
under 10%), a national household survey in Nepal would
need to have a 10-fold higher sample size than the most
recent DHS survey (Table 3). Usefulness of surveys for
interventions in subset target groups is a function of the
prevalence of the clinical need for the intervention (i.e.
denominator) and coverage, thus once KMC coverage
reaches over 50%, then currently used national DHS
sample size may suffice.
Indicators related to treatment for presumed severe
neonatal infection, particularly those related to antibiotic
treatment, may be difficult to capture through surveys.
Among newborns admitted for treatment of presumed
severe infection, we found poor validity in questions
about the baby’s diagnosis and treatment, even with
short recall periods. Previous studies of survey-reported
antibiotic use for childhood illness have shown that
these questions perform poorly and were even worse
with longer recall periods [49]. These studies also found
that maternal reports of symptoms of acute respiratory
infection do not provide a correct denominator for mon-
itoring antibiotic treatment rates [50].
Admission to a neonatal unit for infection may be a
useful contact point indicator as women were able to
report this with high sensitivity. However, similar to
KMC, this exit survey question was only asked toTable 3 Estimated sample size required to measure coverage of
kangaroo mother care in a national household survey
Households needed Bangladesh Nepal Tanzania
5% Coverage 356,197 220,963 268,266
10% Coverage 168,725 104,667 127,074
25% Coverage 56,242 34,889 42,358
50% Coverage 18,747 11,630 14,119
75% Coverage 6249 3877 4706
Last DHS survey 19,457 11,040 12,563
n ¼ 4ðrÞð1 − rÞð fÞð1:1Þð0:12r2ÞðpÞðnhÞ
where:r= predicted coverage
f = design effect = 1.5
p= population proportion of target group (under 5 years and under 2000 g)
nh= household sizewomen with admitted newborns and further research is
required to validate this indicator in a wider population.
Additionally, neonatal infection questions will be subject
to sample size issues similar to KMC as incidence risk of
possible severe bacterial infection is estimated at 7.6%
[47]. Hospital registers and records may be a better
alternative for reporting coverage of interventions for
small target groups such as small and sick newborns.
Specific registers can be designed for documentation of
treatment of infection in neonatal inpatient wards rather
than only maintaining individual case record forms [51].
For indicators already present in DHS/MICS, we
found sex of the baby and low birthweight were reported
accurately, although birthweight is known to have issues
with heaping (preferential reporting of weight with
numbers ending in 00) [35, 46]. Immediate drying had
very high sensitivity but very low specificity, possibly
relating to the timing element. Drying was counted as
“immediate” when it was observed as done within 5 min
of birth while women were asked, “Was your baby dried
or wiped immediately after birth (within a few
minutes)?”. In qualitative interviews with women about
their understanding of the word "immediate" in
questions relating to immediate newborn care,
McCarthy et al. found a wide range of responses
including 1 or 2 min, up to 7 min, and less than 20 min
[30]. Other studies have also shown immediate drying to
have high sensitivity, and low or moderate specificity
alone or as a composite indicator with other immediate
newborn care [27, 28, 30]. Similar to other validation
studies, we found early initiation of breastfeeding was
largely over-estimated by survey-reported coverage. This
over-estimate may be due to poor recall of the timing
component if breastfeeding was initiated but not within
1 h [26, 28, 29]. Furthermore, definitions of breastfeed-
ing may differ between clinical observers and breastfeed-
ing women. A woman may have put her baby to the
breast and considered this initiation of breastfeeding,
but an observer may not have recorded breastfeeding
initiation if they did not observe attachment and suck-
ling, as breastfeeding is a complex and dynamic process
[34, 37]. Survey questions on breastfeeding may be more
accurate if the focus on timing is removed or shifted to
something easier to recall such as place.
While interventions involving women themselves,
(e.g. skin-to-skin contact or initiation of breastfeed-
ing) had low “don’t know” responses, questions re-
garding clinical interventions had high levels of “don’t
know” responses. These indicators had lower accuracy
in survey-reports, even when the recall period was
very short (exit survey) compared with 2 to 5-year re-
call periods expected in population-based surveys.
Low accuracy may relate to not seeing an interven-
tion happening if newborns are separated from their
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care from health care workers. While a study con-
ducted in primary health care facilities in northern
Nigeria found high validity for measurement of Chlor-
hexidine application to newborn’s cord [27], our study
showed low validity in these facilities, possibly due to
not applying Chlorhexidine in front of the mother or
lack of communication between health care workers
and women. A detailed validation analysis for Chlor-
hexidine application is published elsewhere [38].
We have considered “don’t know” replies for most yes/
no survey questions as “no”, consistent with DHS
reporting [40]. We found, however, for clinical
interventions observed coverage was high among women
who responded “don’t know”. While in our study,
observed coverage of these clinical interventions was high
among all newborns in these facilities, true coverage
among women responding “don’t know” to these
questions for home births or births in smaller facilities
may not be as high. Survey-reported coverage of maternal
and newborn care may have improved accuracy if “don’t
know” responses are excluded from both numerators and
denominators.
Strengths and limitations
Strengths of this study include the large sample of
more than 23,000 facility births (> 14,000 exit-surveys
with women with vaginal births) across five high-
burden facilities in three countries from sub-Saharan
Africa and south Asia and direct observation by clin-
ically trained researchers used as gold standard. Er-
rors in data collection for observation were
minimized by using a custom-built android applica-
tion with time-stamping designed to reduce delay in
recording events [52]. Data quality was promoted by
refresher training and subsets of dual observation by
supervisors for comparison [34]. While we did not
base our assessment of validity on AUC cut-offs as
our indicators were all binary (yes/no), we provide
these calculations in Additional files 4 and 10.
This study's limitations included conducting the
survey at the time of discharge from the hospital, in
contrast to several years after birth as is often done in
population-based surveys. As such, the recall bias will
be minimized for our study, representing the best-case
scenario and not the level of validity captured by
population-based surveys. However, as surveys were
conducted at the time of discharge, the busy clinical
setting may have been distracting and women may have
been in a hurry to return home, which may differ from
the context of the population-based surveys occurring
in a home setting. Some bias may have been introduced
as > 5% of women were discharged before they were
approached for interview. We also note that theresults may not be representative of lower-level facil-
ities since EN-BIRTH was conducted in five high-
volume facilities. Additionally, observed coverage of
care may have been higher due to the presence of
the observer, further limiting generalisability and pos-
sibly altering women’s perception and recollection of
care received [12]. In this paper we excluded the
6698 women who had caesarean sections. Since cae-
sarean section affects both the practice of care and
survey report, all our results for many of the 33 indi-
cators would need to be split by caesarean section
non-caesarean, adding even more complexity. These
important analyses will be undertaken later.
The coverage of the indicators for treatment of
presumed severe neonatal infection was reported from
data extraction from individual case notes, as
observation of admitted neonates for the whole hospital
stay was not feasible. There is a possibility that a specific
intervention was given but was not documented in the
case notes. Despite having a large sample, there were
still indicators with very high or low coverage that did
not have enough observations in each column of the
two-way table to report individual-level validity statistics.
For those indicators, we did not report sensitivity, speci-
ficity, AUC and IF, and instead reported percent agree-
ment [12]. The percentage agreement should be
interpreted cautiously as there is the possibility of high
percentage agreement for high sensitivity and low speci-
ficity of indicators that have high coverage. Additionally,
high percentage agreement is also possible where an in-
dicator has low sensitivity and high specificity with very
low coverage.
Rates of caesarean sections are rising globally [53].
In our study, the caesarean section rate was 29%
overall, and as high as 73% in one hospital, Azimpur
BD. Women with vaginal births have different
experiences from women undergoing caesareans and
may experience more separation from their newborns.
Caesarean birth negatively affected accuracy of
survey-reported data [34–38]; thus this analysis has
focused on vaginal birth. Further research of care and
measurement among women with caesareans in this
study is ongoing. Women with stillbirths were in-
cluded in our survey, and coverage and measurement
gaps for stillbirths are shown for specific indicators
throughout this supplement series [35, 54]. The ma-
jority of women with stillbirths approached for survey
consented to participate in and responded to ques-
tions on labour and birth [54], in line with other
research involving women with stillbirths showing
high survey completeness [55]. Women with stillbirths
should be included in population-based surveys,
particularly to inform action to end preventable
stillbirths.
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wording for some survey questions, particularly those
related to clinical interventions or those with a timing
component (i.e. early initiation of breastfeeding), may
improve accuracy. Research on communication
surrounding clinical interventions for newborn care,
including small and sick newborns, is needed to
understand factors contributing to accuracy of survey-
reported coverage. More qualitative research regarding
women’s understanding of and recall for questions re-
lated to timing, such as early breastfeeding and immedi-
ate drying, will allow us to improve question wording or
indicator definitions. More process evaluation is re-
quired to better understand and improve aspects of sur-
veys and survey burden.
Conclusions
Population-based surveys remain an important source of
generalisable maternal and newborn health information,
especially where routine systems are not available.
Among 33 indicators assessed, survey-reported birth-
weight measured and low birthweight classification per-
formed well, however other clinical intervention
questions and early initiation of breastfeeding performed
poorly in survey-report. Further research is needed to
see if differently phrased questions could lead to higher
accuracy. While specific clinical interventions are not
appropriate for surveys, contact indicators such as ad-
mission to a neonatal unit or a KMC ward may be a use-
ful survey indicator option as a marker of care for small
and sick newborns. Given that ~ 80% of births world-
wide are now in facilities, investment in routine health
management information systems could improve poten-
tial for tracking coverage of clinically focused maternal
and newborn health interventions. Household surveys
have numerous questions, and careful evidence-based
measurement approaches should be applied to select
and reject which indicators are best measured in surveys
and/or routine systems based on impact and validity.
Valid measurement is required to track scale-up of high-
impact interventions and end preventable deaths of
women and newborns.
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